University of Cambridge, Genomics England Ltd., and Illumina, Inc.
ILMN today announced the start of a three-year project that
will sequence 10,000 whole genomes of children and adults with rare
genetic diseases. The project represents a pilot for Genomics England
Ltd., which will provide 2,000 samples, and marks the beginning of the
national endeavor to sequence 100,000 genomes in the UK National Health
Service (NHS), announced recently by the Prime Minister, David Cameron.
“This project will bring enormous improvements to the care of patients
with rare genetic diseases. It will shorten the gap between the first
signs of ill-health in a person and providing a conclusive diagnosis by
using the power of modern DNA sequencing methods,” said Dr. John
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in